Importation of unlicensed medicines and centrally authorised products - a helpful reminder
Posted by:
Mark Birse, Posted on:
-
Categories:
Compliance matters, Good distribution practice, Good manufacturing practice
We have recently had a number of situation where importers of unlicensed medicines have attempted to notify MHRA of centrally authorised products for import as unlicensed medicines. This is not appropriate, as these are not unlicensed medicines and should be distributed …
